These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8748120)

  • 21. Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress.
    Wagner KV; Wang XD; Liebl C; Scharf SH; Müller MB; Schmidt MV
    Psychoneuroendocrinology; 2011 May; 36(4):579-87. PubMed ID: 20940090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age- and stimulus-dependent changes in anxiety-related behaviour of transgenic mice with GR dysfunction.
    Ströhle A; Poettig M; Barden N; Holsboer F; Montkowski A
    Neuroreport; 1998 Jun; 9(9):2099-102. PubMed ID: 9674601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
    Kier A; Han J; Jacobson L
    Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of antidepressive agents on tolerance of hypoxia and physical exercise].
    Andreeva NI; Golovina SM; Parshin VA; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1991 Aug; 112(8):156-8. PubMed ID: 1786375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactive compounds from Paecilomyces tenuipes regulating the function of the hypothalamo-hypophyseal system axis in chronic unpredictable stress rats.
    Yin YY; Ming L; Zheng LF; Kan HW; Li CR; Li WP
    Chin Med J (Engl); 2007 Jun; 120(12):1088-92. PubMed ID: 17637227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function.
    Steckler T; Holsboer F
    Behav Brain Res; 1999 Jul; 102(1-2):151-63. PubMed ID: 10403023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
    Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
    Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
    Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
    Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1997 May; 131(2):180-6. PubMed ID: 9201807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E; Chodera A; Kus K; Rybakowski J
    Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.
    Villarinho JG; Fachinetto R; de Vargas Pinheiro F; da Silva Sant'Anna G; Machado P; Dombrowski PA; da Cunha C; de Almeida Cabrini D; Pinto Martins MA; Gauze Bonacorso H; Zanatta N; Antonello Rubin M; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):31-9. PubMed ID: 22525823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
    Barden N
    J Psychiatry Neurosci; 2004 May; 29(3):185-93. PubMed ID: 15173895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.
    Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Szponar J; Doboszewska U; Wlaź P; Wlaź A; Serefko A
    Pharmacol Rep; 2020 Dec; 72(6):1562-1572. PubMed ID: 32221841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of dextromethorphan metabolism by moclobemide.
    Härtter S; Dingemanse J; Baier D; Ziegler G; Hiemke C
    Psychopharmacology (Berl); 1998 Jan; 135(1):22-6. PubMed ID: 9489930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T cell trafficking and T cell responsiveness during postnatal development.
    Morale MC; Batticane N; Gallo F; Barden N; Marchetti B
    Endocrinology; 1995 Sep; 136(9):3949-60. PubMed ID: 7649104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor.
    Stec I; Barden N; Reul JM; Holsboer F
    J Psychiatr Res; 1994; 28(1):1-5. PubMed ID: 8064637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR; Burrows GD
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression.
    Pepin MC; Pothier F; Barden N
    Mol Pharmacol; 1992 Dec; 42(6):991-5. PubMed ID: 1480137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.